Drug Improves Renal Function in Diabetic CKD Patients

Share this content:


An experimental anti-inflammatory agent called bardoxolone methyl improves renal function in CKD patients with type 2 diabetes, according to researchers. John Schieszer has the story in today's Medical Minute.
You must be a registered member of Renal and Urology News to post a comment.

Sign Up for Free e-newsletters